880 related articles for article (PubMed ID: 23089684)
1. Similarity in recombination rate and linkage disequilibrium at CYP2C and CYP2D cytochrome P450 gene regions among Europeans indicates signs of selection and no advantage of using tagSNPs in population isolates.
Pimenoff VN; Laval G; Comas D; Palo JU; Gut I; Cann H; Excoffier L; Sajantila A
Pharmacogenet Genomics; 2012 Dec; 22(12):846-57. PubMed ID: 23089684
[TBL] [Abstract][Full Text] [Related]
2. Global pharmacogenomics: Impact of population diversity on the distribution of polymorphisms in the CYP2C cluster among Brazilians.
Suarez-Kurtz G; Genro JP; de Moraes MO; Ojopi EB; Pena SD; Perini JA; Ribeiro-dos-Santos A; Romano-Silva MA; Santana I; Struchiner CJ
Pharmacogenomics J; 2012 Jun; 12(3):267-76. PubMed ID: 21173785
[TBL] [Abstract][Full Text] [Related]
3. Linkage disequilibrium between the CYP2C19*17 allele and wildtype CYP2C8 and CYP2C9 alleles: identification of CYP2C haplotypes in healthy Nordic populations.
Pedersen RS; Brasch-Andersen C; Sim SC; Bergmann TK; Halling J; Petersen MS; Weihe P; Edvardsen H; Kristensen VN; Brøsen K; Ingelman-Sundberg M
Eur J Clin Pharmacol; 2010 Dec; 66(12):1199-205. PubMed ID: 20665013
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation in the CYP2C monooxygenase enzyme subfamily shows no association with longevity in a German population.
Flachsbart F; Ufer M; Kleindorp R; Nikolaus S; Schreiber S; Nebel A
J Gerontol A Biol Sci Med Sci; 2011 Nov; 66(11):1186-91. PubMed ID: 21798861
[TBL] [Abstract][Full Text] [Related]
5. Multi-ethnic distribution of clinically relevant CYP2C genotypes and haplotypes.
Martis S; Peter I; Hulot JS; Kornreich R; Desnick RJ; Scott SA
Pharmacogenomics J; 2013 Aug; 13(4):369-77. PubMed ID: 22491019
[TBL] [Abstract][Full Text] [Related]
6. Sequence variation and linkage disequilibrium in the GABA transporter-1 gene (SLC6A1) in five populations: implications for pharmacogenetic research.
Hirunsatit R; Ilomäki R; Malison R; Räsänen P; Ilomäki E; Kranzler HR; Kosten T; Sughondhabirom A; Thavichachart N; Tangwongchai S; Listman J; Mutirangura A; Gelernter J; Lappalainen J
BMC Genet; 2007 Oct; 8():71. PubMed ID: 17941974
[TBL] [Abstract][Full Text] [Related]
7. Linkage disequilibrium between the CYP2C19*17 allele and other clinically important CYP2C allelic variants in a healthy Scandinavian population.
Pedersen RS; Christensen MM; Brøsen K
Eur J Clin Pharmacol; 2012 Oct; 68(10):1463-4. PubMed ID: 22476388
[No Abstract] [Full Text] [Related]
8. Distribution of polymorphisms in the CYP2C9 gene and CYP2C19/CYP2C9 haplotypes among Venezuelan populations.
Flores-Gutiérrez S; Rodríguez-Larralde Á; Vívenes de Lugo M; Castro de Guerra D
Ann Hum Biol; 2017 Mar; 44(2):191-198. PubMed ID: 27230833
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants in CYP (-1A2, -2C9, -2C19, -3A4 and -3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversity.
Dandara C; Lombard Z; Du Plooy I; McLellan T; Norris SA; Ramsay M
Pharmacogenomics; 2011 Dec; 12(12):1663-70. PubMed ID: 22118051
[TBL] [Abstract][Full Text] [Related]
10. Comparison of linkage disequilibrium patterns and haplotype structure of eight single nucleotide polymorphisms across the CYP1A2 gene between the Korean, and other populations registered in the International HapMap database.
Woo SW; Kang TS; Park HJ; Lee JE; Roh J
J Clin Pharm Ther; 2009 Aug; 34(4):429-36. PubMed ID: 19583676
[TBL] [Abstract][Full Text] [Related]
11. Linkage disequilibrium and haplotype block patterns in popcorn populations.
Andrade ACB; Viana JMS; Pereira HD; Pinto VB; Fonseca E Silva F
PLoS One; 2019; 14(9):e0219417. PubMed ID: 31553737
[TBL] [Abstract][Full Text] [Related]
12. SNP identification, linkage disequilibrium, and haplotype analysis for a 200-kb genomic region in a Korean population.
Kim KJ; Lee HJ; Park MH; Cha SH; Kim KS; Kim HT; Kimm K; Oh B; Lee JY
Genomics; 2006 Nov; 88(5):535-40. PubMed ID: 16919420
[TBL] [Abstract][Full Text] [Related]
13. Novel variants of major drug-metabolising enzyme genes in diverse African populations and their predicted functional effects.
Matimba A; Del-Favero J; Van Broeckhoven C; Masimirembwa C
Hum Genomics; 2009 Jan; 3(2):169-90. PubMed ID: 19164093
[TBL] [Abstract][Full Text] [Related]
14. Identification of the polymorphically expressed CYP2C19 and the wild-type CYP2C9-ILE359 allele as low-Km catalysts of cyclophosphamide and ifosfamide activation.
Chang TK; Yu L; Goldstein JA; Waxman DJ
Pharmacogenetics; 1997 Jun; 7(3):211-21. PubMed ID: 9241661
[TBL] [Abstract][Full Text] [Related]
15. Linkage disequilibrium patterns and tagSNP transferability among European populations.
Mueller JC; Lõhmussaar E; Mägi R; Remm M; Bettecken T; Lichtner P; Biskup S; Illig T; Pfeufer A; Luedemann J; Schreiber S; Pramstaller P; Pichler I; Romeo G; Gaddi A; Testa A; Wichmann HE; Metspalu A; Meitinger T
Am J Hum Genet; 2005 Mar; 76(3):387-98. PubMed ID: 15637659
[TBL] [Abstract][Full Text] [Related]
16. Inactive alleles of cytochrome P450 2C19 may be positively selected in human evolution.
Janha RE; Worwui A; Linton KJ; Shaheen SO; Sisay-Joof F; Walton RT
BMC Evol Biol; 2014 Apr; 14():71. PubMed ID: 24690327
[TBL] [Abstract][Full Text] [Related]
17. A worldwide survey of haplotype variation and linkage disequilibrium in the human genome.
Conrad DF; Jakobsson M; Coop G; Wen X; Wall JD; Rosenberg NA; Pritchard JK
Nat Genet; 2006 Nov; 38(11):1251-60. PubMed ID: 17057719
[TBL] [Abstract][Full Text] [Related]
18. Haplotype structures of common variants of CYP2C8, CYP2C9, and ADRB1 genes in a South Indian population.
Arun Kumar AS; Chakradhara Rao US; Umamaheswaran G; Ramu P; Kesavan R; Shewade DG; Balachandar J; Adithan C
Genet Test Mol Biomarkers; 2011 Jun; 15(6):407-13. PubMed ID: 21375401
[TBL] [Abstract][Full Text] [Related]
19. Recombination hotspots and block structure of linkage disequilibrium in the human genome exemplified by detailed analysis of PGM1 on 1p31.
Rana NA; Ebenezer ND; Webster AR; Linares AR; Whitehouse DB; Povey S; Hardcastle AJ
Hum Mol Genet; 2004 Dec; 13(24):3089-102. PubMed ID: 15509594
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of drug-metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population.
Arvanitidis K; Ragia G; Iordanidou M; Kyriaki S; Xanthi A; Tavridou A; Manolopoulos VG
Fundam Clin Pharmacol; 2007 Aug; 21(4):419-26. PubMed ID: 17635181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
